Supplemental Choline Modulates Growth Performance and Gut Inflammation by Altering the Gut Microbiota and Lipid Metabolism in Weaned Piglets

J Nutr. 2021 Jan 4;151(1):20-29. doi: 10.1093/jn/nxaa331.

Abstract

Background: Whether dietary choline and bile acids affect lipid use via gut microbiota is unclear.

Objectives: This study aimed to investigate the effect of choline and bile acids on growth performance, lipid use, intestinal immunology, gut microbiota, and bacterial metabolites in weaned piglets.

Methods: A total of 128 weaned piglets [Duroc × (Landrace × Yorkshire), 21-d-old, 8.21 ± 0.20 kg body weight (BW)] were randomly allocated to 4 treatments (8 replicate pens per treatment, each pen containing 2 males and 2 females; n = 32 per treatment) for 28 d. Piglets were fed a control diet (CON) or the CON diet supplemented with 597 mg choline/kg (C), 500 mg bile acids/kg (BA) or both (C + BA) in a 2 × 2 factorial design. Growth performance, intestinal function, gut microbiota, and metabolites were determined.

Results: Compared with diets without choline, choline supplementation increased BW gain (6.13%), average daily gain (9.45%), gain per feed (8.18%), jejunal lipase activity (60.2%), and duodenal IL10 gene expression (51%), and decreased the mRNA abundance of duodenal TNFA (TNFα) (40.7%) and jejunal toll-like receptor 4 (32.9%) (P < 0.05); additionally, choline increased colonic butyrate (29.1%) and the abundance of Lactobacillus (42.3%), while decreasing the bile acid profile (55.8% to 57.6%) and the abundance of Parabacteroides (75.8%), Bacteroides (80.7%), and unidentified-Ruminococcaceae (32.5%) (P ≤ 0.05). Compared with diets without BA, BA supplementation decreased the mRNA abundance of colonic TNFA (37.4%), NF-κB p65 (42.4%), and myeloid differentiation factor 88 (42.5%) (P ≤ 0.01); BA also increased colonic butyrate (20.9%) and the abundance of Lactobacillus (39.7%) and Faecalibacterium (71.6%) and decreased that of Parabacteroides (67.7%) (P < 0.05).

Conclusions: Choline supplementation improved growth performance and prevented gut inflammation in weaned piglets by altering gut microbiota and lipid metabolism. BA supplementation suppressed intestinal inflammation with no effect on growth performance, which was associated with changed gut microbiota and metabolites.

Keywords: bacterial metabolites; bile acids; choline; growth performance; gut inflammation; gut microbiota; lipid use; weaned piglets.

Publication types

  • Randomized Controlled Trial, Veterinary
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bile Acids and Salts / administration & dosage
  • Bile Acids and Salts / pharmacology
  • Choline / administration & dosage*
  • Cytokines / genetics
  • Cytokines / metabolism
  • Dietary Supplements
  • Female
  • Gastrointestinal Microbiome / drug effects*
  • Gene Expression Regulation / drug effects
  • Inflammation / veterinary*
  • Intestinal Diseases / prevention & control
  • Intestinal Diseases / veterinary*
  • Lipid Metabolism / drug effects*
  • Male
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Swine / growth & development*
  • Swine Diseases / prevention & control
  • Transcriptome

Substances

  • Bile Acids and Salts
  • Cytokines
  • Receptors, Cytoplasmic and Nuclear
  • farnesoid X-activated receptor
  • Choline